Connor Clark & Lunn Investment Management Ltd. Raises Stake in Inogen, Inc. (NASDAQ:INGN)

Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Inogen, Inc. (NASDAQ:INGN) by 42.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 248,822 shares of the medical technology company’s stock after acquiring an additional 74,197 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Inogen were worth $2,282,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. AlphaQuest LLC acquired a new position in Inogen in the fourth quarter valued at approximately $43,000. Quarry LP acquired a new position in shares of Inogen in the 3rd quarter valued at $59,000. Ieq Capital LLC purchased a new position in shares of Inogen during the 4th quarter worth $94,000. Verition Fund Management LLC purchased a new position in shares of Inogen during the 3rd quarter worth $106,000. Finally, Virtu Financial LLC acquired a new stake in shares of Inogen during the 3rd quarter worth about $111,000. Institutional investors and hedge funds own 89.94% of the company’s stock.

Wall Street Analysts Forecast Growth

INGN has been the topic of a number of recent analyst reports. StockNews.com cut shares of Inogen from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Needham & Company LLC restated a “hold” rating on shares of Inogen in a report on Wednesday, February 26th.

Inogen Trading Down 2.3 %

Shares of NASDAQ INGN opened at $7.33 on Wednesday. The stock has a market capitalization of $194.46 million, a PE ratio of -3.26 and a beta of 1.15. Inogen, Inc. has a twelve month low of $6.14 and a twelve month high of $13.33. The stock has a fifty day simple moving average of $9.88 and a 200-day simple moving average of $9.76.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.